To the study the role of vitamin D3 injection for treating cutaneous warts
Not Applicable
- Registration Number
- CTRI/2018/05/013908
- Lead Sponsor
- Dr Shrini Parikh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 patients having cutaneous warts
2 patients > 18 years
3 patients with no prior treatment with either topical or destructive modalities for atleast 6 months
Exclusion Criteria
1 patients < 18 years
2 pregnant and lactating females
3 any evidence of immunosuppression including HIV
4 prior history of hypersensitivity to vitamin D3
5 previously diagnosed renal disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method regression of cutaneous wartsTimepoint: 2 weekly intervals for a maximum of 4 sessions
- Secondary Outcome Measures
Name Time Method to prevent recurrence of wartsTimepoint: for upto 6 months after resolution of warts